1. Home
  2. SOLS vs JAZZ Comparison

SOLS vs JAZZ Comparison

Compare SOLS & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOLS

Solstice Advanced Materials Inc.

N/A

Current Price

$65.72

Market Cap

10.1B

Sector

Industrials

ML Signal

N/A

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$165.30

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOLS
JAZZ
Founded
2025
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
10.4B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
SOLS
JAZZ
Price
$65.72
$165.30
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$63.33
$207.19
AVG Volume (30 Days)
2.5M
1.1M
Earning Date
02-11-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$3,812,000,000.00
$4,157,832,999.00
Revenue This Year
$3.21
$6.00
Revenue Next Year
$3.83
$6.35
P/E Ratio
$30.09
N/A
Revenue Growth
4.47
4.14
52 Week Low
$40.43
$95.49
52 Week High
$64.31
$182.99

Technical Indicators

Market Signals
Indicator
SOLS
JAZZ
Relative Strength Index (RSI) 79.13 47.44
Support Level $61.10 $165.01
Resistance Level $64.31 $171.70
Average True Range (ATR) 2.48 5.62
MACD 0.61 -0.37
Stochastic Oscillator 98.40 54.34

Price Performance

Historical Comparison
SOLS
JAZZ

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: